Peter McCullough on health: what the evidence says · JRE #1747
“we've had 146 million people who've had the respiratory infection. Less than 1% died. Right. But the ones that have gotten the injection and died or got myocarditis”
What the evidence says
McCullough contrasted a sub-1% COVID-19 case fatality figure with vaccine recipients who "died or got myocarditis," implying a comparable scale of harm from vaccination. CDC's national passive-surveillance system (VAERS) explicitly states that a report of death or illness following vaccination does not, by itself, establish that the vaccine caused the event, since anyone can submit a VAERS report regardless of cause. CDC's own review of confirmed myocarditis cases found about 1,226 VAERS reports of myocarditis following mRNA vaccination out of roughly 296 million doses administered through mid-2021, a rate several orders of magnitude smaller than the population-wide scale implied by comparing it to overall infection outcomes; the condition was rare, occurred predominantly in young males after a second dose, and was typically mild and resolved with care. A large prospective safety-surveillance study of over 10 million vaccine-eligible people in the Vaccine Safety Datalink found no statistically significant increase in serious adverse outcomes, including cardiac events, in the 21 days after mRNA vaccination compared with a later comparison window. Current evidence characterizes vaccine-associated death as exceedingly rare and myocarditis as an uncommon, mostly mild, age- and sex-stratified risk, not a mortality or injury burden approaching the scale of COVID-19's fatality toll as the quote implies.
- About the Vaccine Adverse Event Reporting System (VAERS) | Vaccine Safety Systems | CDC · government
- Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices, United States, June 2021 · government
- Surveillance for Adverse Events After COVID-19 mRNA Vaccination · government